Both in Biotechnology
SAB Biotherapeutics vs Lexeo Therapeutics
Over the past year SABS returned −6.3% and LXEO returned −69.7%; their daily moves had a correlation of 0.24.
SABS −6.3% LXEO −69.7%Growth of $1, one year, split-adjusted
| Metric | SABS | LXEO |
|---|---|---|
| Price | $2.84 | $2.80 |
| Market cap | $258.4M | $229.8M |
| Today | −6.58% | −3.11% |
| 1 month | −15.2% | −17.4% |
| 6 months | −19.3% | −52.1% |
| Year to date | −24.1% | −71.8% |
| 1 year | −5.3% | −69.7% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $99.4M | $211.1M |
| Dividend yield | — | — |
| Volatility (60d) | 52.4% | 67.6% |
| Short % of float | 5.5% | 25.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).